The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Eli Lilly (NYSE:LLY ... The latest executive order on drug prices by President Donald Trump has only added to its woes, or has it? The order signed on May 12 aims to align U.S. drug prices ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

The Trump administration is targeting pharmaceutical companies with an executive order aimed at lowering U.S. drug prices ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald Trump would sign an order lowering some drug prices. A surprise trade ...

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

This proves that Eli Lilly's obesity drug Zepbound, as a GLP-1/GIP agonist ... could benefit from any potential gains made here. In order for patients to be recruited into this specific study ...